Citigroup
CPIX icon

Citigroup’s Cumberland Pharmaceuticals CPIX Stock Holding History

Citigroup’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$12 – 6131
2025
Q3 		$12 Buy
+4
New +$13 ﹤0.01% 5931
2022
Q2 		– Sell
-3,453
Closed -$10K – 6288
2022
Q1 		$10K Buy
+3,453
New +$11.5K ﹤0.01% 5521
2016
Q3 		– Sell
-1,200
Closed -$5K – 7067
2016
Q2 		$5K Hold
1,200
– – ﹤0.01% 6766
2016
Q1 		$5K Hold
1,200
– – ﹤0.01% 6986
2015
Q4 		$6K Sell
1,200
-300
-20% -$1.71K ﹤0.01% 6962
2015
Q3 		$9K Sell
1,500
-500
-25% -$3.12K ﹤0.01% 6481
2015
Q2 		$14K Hold
2,000
– – ﹤0.01% 6288
2015
Q1 		$13K Sell
2,000
-410
-17% -$2.56K ﹤0.01% 6325
2014
Q4 		$14K Sell
2,410
-401
-14% -$2.06K ﹤0.01% 6359
2014
Q3 		$14K Sell
2,811
-300
-10% -$1.45K ﹤0.01% 6090
2014
Q2 		$14K Sell
3,111
-692
-18% -$3.09K ﹤0.01% 6006
2014
Q1 		$17K Buy
3,803
+52
+1% +$247 ﹤0.01% 6113
2013
Q4 		$19K Sell
3,751
-785
-17% -$3.83K ﹤0.01% 6195
2013
Q3 		$21K Sell
4,536
-261
-5% -$1.3K ﹤0.01% 5882
2013
Q2 		$24K Buy
+4,797
New +$23.9K ﹤0.01% 5742

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup's CPIX Position: Q4 2025 in Review

Citigroup sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2025, closing a stake of 4 shares — an estimated $12 sold.

Citigroup first reported a position in CPIX in Q2 2013 and held it in 15 quarters. The position peaked at $24K in Q2 2013. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2025.

  • Citigroup reported no remaining Cumberland Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Citigroup sold 4 Cumberland Pharmaceuticals shares in Q4 2025, an estimated $12.
  • Citigroup first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Citigroup's Cumberland Pharmaceuticals position peaked at $24K in Q2 2013.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.